CST 2015 / Cell_Cycle_G1S
.pdfCELL SIGNALING TECHNOLOGY |
|
|
|
|
www.cellsignal.com |
Cell Cycle Control: G1/S Checkpoint |
|||||
|
|
Growth Factor |
|
|
|
|
|
Receptor Activation |
|
|
|
|
|
|
Akt |
|
DNA |
Replicative |
|
TGF-β |
|
|
|
|
|
|
Damage |
||
Senescence |
|
|
FoxO1/3 |
|
|
|
|
|
|
|
|
Differentiation |
|
|
|
|
ATM/ |
|
|
|
|
|
ATR |
Hormones |
|
Smad3 |
|
|
|
BMI1 |
Myc |
|
|
||
Smad4 |
|
p53 |
|||
|
|
|
|
||
Ultra Violet |
|
|
|
|
Replicative |
Stress Response |
|
|
|
|
Senescence |
p19 INK4D p18 INK4C p16 INK4A |
p15 INK4B |
|
p21 Cip1 |
Chk1/2 |
|
|
|
||||
|
|
|
|||
Growth |
|
Myc |
p27 Kip1 |
|
Ubiquitination |
|
|
|
|||
Factor |
|
|
|
|
|
Withdrawal |
|
|
|
|
|
Myc |
|
cdc25A |
|
Myc |
|
GSK-3β |
|
|
|
|
|
|
|
|
|
SCF |
|
|
|
|
|
|
CDK4/6
Ubiquitination Cyclin D
|
|
|
|
|
E |
|
|
|
|
S |
|
|
|
|
A |
|
|
|
|
H |
|
|
|
|
P |
|
|
|
|
|
- |
|
|
|
|
1 |
|
|
|
|
|
G |
|
|
|
|
|
CDK2
R |
Cyclin E |
|
S- |
|
|
|
|
|
|
P |
|
|
|
H |
|
|
A |
|
|
S |
|
|
E |
Ubiquitination
|
|
|
|
|
|
|
|
Suv39H1 |
|
|
|
|
|
|
|
E2F/DP Target Genes: |
|||||
|
|
|
|
|
|
|
Abl Rb HDAC |
Rb |
|
|
|
|
|||||||||
|
FoxO1 |
|
Bim |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cyclin E/A, E2F-1/2/3, |
|
|
|
|
|
|
E2F |
|
|
|
|
|
E2F |
cdc2, c-Myc, p107, |
||||||||
|
|
|
FasL |
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RanGAP, TK, DHFR, |
|
|
DBE |
|
|
Apoptosis |
|
DP-1 |
|
|
|
|
|
|
|
|
|
DP-1 |
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
TRAIL |
|
|
|
|
|
OFF |
|
|
|
|
|
|
ON |
PCNA, H2A, etc. |
Pathway Diagram Keys
Kinase |
Enzyme |
|
G-protein |
|
|
|
|
|
Direct Inhibitory |
|
Tentative Inhibitory |
|
|
Translocation |
||||||||
Phosphatase |
pro-apoptotic |
|
Acetylase |
|
Modification |
|
Modification |
|
|
|
Transcriptional |
|||||||||||
|
|
|
|
|
|
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
Multistep Stimulatory |
|
|
|
|
Separation of Subunits |
|
|
Stimulatory Modification |
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Transcription Factor |
pro-survival |
|
Deacetylase |
|
Modification |
|
or Cleavage Products |
|
|
|
Transcriptional |
|||||||||||
|
|
|
|
|
|
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Caspase |
GAP/GEF |
|
|
|
|
|
|
|
|
|
Multistep Inhibitory |
|
|
|
Joining of Subunits |
|
|
Inhibitory Modification |
||||
|
Ribosomal subunit |
|
Modification |
|
|
|
|
|
|
|
||||||||||||
Receptor |
GTPase |
|
Direct Stimulatory |
|
Tentative Stimulatory |
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||
|
|
Modification |
|
Modification |
|
|
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
© 2002 – 2014 Cell Signaling Technology, Inc.